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Estimates of the numbers and rates of acute decompensated heart failure (ADHF) hospitalization are central to
understanding health-care utilization and efforts to improve patient care. We comprehensively estimated the fre-
quency, rate, and trends of ADHF hospitalization in the United States. Based on Atherosclerosis Risk in Commu-
nities (ARIC) Study surveillance adjudicating 12,450 eligible hospitalizations during 2005–2010, we developed
prediction models for ADHF separately for 3 International Classification of Diseases, Ninth Revision, Clinical Mod-
ification (ICD-9-CM) code 428 discharge diagnosis groups: 428 primary, 428 nonprimary, or 428 absent.We applied
the models to data from the National Inpatient Sample (11.5 million hospitalizations of persons aged ≥55 years with
eligible ICD-9-CM codes), an all-payer, 20% probability sample of US community hospitals. The average estimated
number of ADHF hospitalizations per year was 1.76 million (428 primary, 0.80 million; 428 nonprimary, 0.83 million;
428 absent, 0.13 million). During 1998–2004, the rate of ADHF hospitalization increased by 2.0%/year (95% con-
fidence interval (CI): 1.8, 2.5) versus a 1.4%/year (95% CI: 0.8, 2.1) increase in code 428 primary hospitalizations
(P < 0.001). In contrast, during 2005–2011, numbers of ADHF hospitalizations were stable (−0.5%/year; 95% CI:
−1.4, 0.3), while the numbers of 428-primary hospitalizations decreased by −1.5%/year (95%CI: −2.2, −0.8) (P for
contrast = 0.03). In conclusion, the estimated number of hospitalizations with ADHF is approximately 2 times higher
than the number of hospitalizations with ICD-9-CM code 428 in the primary position. The trend increased more
steeply prior to 2005 and was relatively flat after 2005.
acute decompensated heart failure; adjudicated heart failure; community surveillance; hospitalizations;
International Classification of Diseases codes; national inpatient sample; secular trends; United States
Abbreviations: ADHF, acute decompensated heart failure; ARIC, Atherosclerosis Risk in Communities; AUC, area under the
receiver operating characteristic curve; CI, confidence interval; ICD-9-CM, International Classification of Diseases, Ninth Revision,
Clinical Modification; NIS, National Inpatient Sample; PPV, positive predictive value; SE, standard error.
Estimates of the numbers and rates of acute decompen-
sated heart failure (ADHF) hospitalization are central to our
understanding of health-care utilization and to efforts to im-
prove patient care and reduce cost through policy measures.
There are more than 5.7 million Americans living with heart
failure, an estimate projected to increase to more than 8 mil-
lion by the year 2030 (1). Annual mortality following an
ADHF hospitalization is about 30% (2).
An ADHF episode is understood as a clinical state of heart
failure that requires either initiation or escalation of treatment
to relieve acute symptoms or to prevent death. National esti-
mates of ADHF have been hampered by its syndromic nature,
with nonspecific signs and symptoms, thus requiring vali-
dation of each hospitalization, a costly and time-intensive
process (3).
National estimates of the numbers and rates of ADHF hos-
pitalization have focused on International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-
CM) discharge code 428 in the primary position on the hos-
pital discharge form, the frequency and rates of which have
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declined over the past decade (4–7). Previous studies from
the United States (8, 9) and Europe (10, 11) have found a
high specificity but poor sensitivity of ICD-9-CM code 428
in the primary position. Thus, ICD-9-CM code 428 in the pri-
mary position probably underestimates numbers of ADHF
hospitalizations (9). Indeed, hospitalizations with a nonpri-
mary ICD-9-CM 428 code are 3 times more common than
thosewith a primary 428 code, and they doubled in frequency
from 1979 to 2004 (6, 12). It is also known that some ADHF
hospitalizations may have ICD-9-CM codes other than 428
(e.g., cardiomyopathy—code 425; pulmonary heart disease
including cor pulmonale—code 415/416) (8, 10).
To comprehensively estimate the burden of ADHF in the
United States, we derived prediction models for adjudicated
ADHF cases based on community-based Atherosclerosis
Risk in Communities (ARIC) Study ADHF surveillance data
from diverse community hospitals in 4 geographically de-
fined areas. We applied these models to data from the Na-
tional Inpatient Sample (NIS) to estimate the number and
rate of ADHF hospitalization in the United States from
1998 through 2011. We tested the robustness of the estimates
using simple versus complex prediction models for ADHF.
We compared trends in these new ADHF hospitalization es-
timates with estimates of ICD-9-CM 428 codes in the pri-
mary position.
METHODS
Study samples
Derivation sample. In the Community Surveillance
Component of the ARIC Study, epidemiologic surveillance
for hospitalized ADHF among the residents of 4 US com-
munities aged ≥55 years began in 2005 (n = 21 hospitals).
A sample of hospitalizations with eligible ICD-9-CM codes
in any position on the discharge form (code 428.x and non-
428 codes 398.91, 402.01, 402.11, 402.91, 404.01, 404.03,
404.11, 404.13, 404.91, 404.93, 415.0, 416.9, 425.4, 518.4,
and 786.0x), stratified by ICD-9-CM code, sex, and race, was
selected for 2005–2010.
Medical records were abstracted by trained study staff ad-
hering to a common protocol (9). A panel of physician re-
viewers, assisted by computerized algorithms, adjudicated
hospitalizations as definite or possible ADHF (9). Hospitali-
zations for chronic heart failure were adjudicated and classi-
fied as not ADHF. Data for event years 2005–2010 were
available and included in this analysis.
Application sample. Models predictive of ADHF (defi-
nite or possible) developed in the ARIC Community Surveil-
lance Component were applied to data from the NIS, the
largest publicly available all-payer hospitalization database.
The NIS is a stratified sample of approximately 20% of US
community hospitals, and in 2011 it included over 1,000 hos-
pitals sampled from 46 participating states (13). Sampling
methods have been consistent since 1998 (13). Among the
potential sources of national data, including the National
Hospital Discharge Survey, the NIS was selected for these
analyses to facilitate comparison with recently published re-
ports that used NIS data (6, 7). The NIS also benefitted from
its consistent sampling methods during the study period,
larger sampling fractions, and availability of information on
health-care utilization. Our analyses included eligible hospi-
talizations matching ARIC eligibility criteria (Figure 1).
From the 57.9 million hospitalizations sampled during 1998–
2011, we excluded those without eligible discharge codes
(46.1 million), those with patient age <55 years (0.2 million),
and those with missing information on sex (n = 781), which
left us with 11.5 million hospitalizations.
Predictors of ADHF
Predictors were considered only if data were available in
both the validation and application samples. They included
age group (55–<65, 65–<75, or ≥75 years), sex, race (Cauca-
sian vs. other), teaching hospital status, and ICD-9-CM dis-
charge codes. A consistent algorithm was used across the two
databases to define the presence and position of the 428 dis-
charge codes, other heart failure codes (see Web Table 1,
available at http://aje.oxfordjournals.org/), and comorbidity
codes (Web Table 2). The first occurrence of a code among
25 available code positions was used to categorize its position,
with the first position used to denote the primary code. Race
was unrelated to ADHF validation, and missing information
on race in the NIS (23%) was coded as non-Caucasian.
Statistical methods
Derivation of models in the ARIC Study to predict ADHF.
We estimated unadjusted positive predictive value (PPV)
and developedmodels of adjusted PPV (“validation models”)
for 3 mutually exclusive groups, known a priori to have dif-
ferent average probabilities of ADHF. Groups were defined
by the presence of ICD-9-CM code 428 and its position:
428 primary, 428 nonprimary, and 428 absent (non-428 eli-
gible codes). We estimated PPV for the 3 ICD-9-CM 428
code groups while accounting for the stratified sampling.
Web Table 3 shows PPVs by 428 group in the presence of
additional comorbidity. We then employed a structured ap-
proach to build multivariable validation models, using logis-
tic regression to predict ADHF by ICD-9-CM 428 group
(Web Appendix, Web Tables 4–6, and Figure 1). The internal
validity of the final models was assessed using the area under
the receiver operating characteristic curve (AUC) and the cal-
ibration slope corrected for optimism (14). We also examined
plots of the observed versus expected proportions of ADHF
by decile of heart failure risk score, and we fitted models with
interaction terms in order to assess consistency of model fit
across ARIC study sites and study years.
Application of the models to predict ADHF in the NIS data-
base. We applied unadjusted PPV estimates and the valida-
tion models to the NIS data to estimate the probability of
ADHF for each hospitalization in the NIS by ICD-9-CM
428 group. The sum of probabilities yielded ADHF esti-
mates. The models accounted for differences in comorbidity
and study years between the two studies. The variance in
ADHF estimates was obtained via the delta method (Web
Appendix). Per NIS analytical guidelines, all analyses were
weighted to represent all US community hospitals, and vari-
ance estimates accounted for the stratified sampling design
(15). To estimate rates, we used yearly US intercensal estimates
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as denominators (16). Average annual percent change in
number or rate of hospitalization was estimated on the basis
of regression models of annual log counts or rates, with in-
verse variance weighting, overall and separately for equal
7-year periods (1998–2004 and 2005–2011). We tested dif-
ferences in the annual change of ADHF hospitalizations over-
all versus those with code 428 in the primary position using
an interaction term for interaction between a 428-primary
indicator term and calendar year. The analysis of trends
was repeated in strata defined by age group (55–64, 65–74,
and ≥75 years). All analyses were conducted using survey
procedures in SAS 9.3 (SAS Institute, Inc., Cary, North Ca-
rolina) and SUDAAN (RTI International, Research Triangle
Park, North Carolina).
RESULTS
During 2005–2010, investigators with the Community
Surveillance Component of the ARIC Study reviewed 12,450
eligible hospitalizations (weighted to 52,065) representing 4
communities. Patient characteristics in eligible ARIC hospi-
talizations and 11.5 million NIS hospitalizations (weighted
to 57.0 million nationally during 1998–2011) were largely
similar (Table 1). The mean age, percent female, proportion
of sampled codes, and percent admitted to a teaching hospital
were similar across the 2 samples (Web Tables 7 and 8). El-
igible hospitalizations in the ARIC Community Surveillance
Component had a higher prevalence of uncomplicated hy-
pertension, diabetes, chronic kidney disease, acute kidney in-
jury, and anemia than those in the NIS and a lower prevalence
of atrial fibrillation than the NIS (Table 1). Validation models
were adjusted for the above variables and other covariates in
Table 1 when related to ADHF.
ADHF hospitalization validation models and burden
TheADHFvalidationPPVwas 90.2% (standard error (SE),
0.8%) for code 428 primary, 32.2% (SE, 0.6%) for code
428 nonprimary, and 16.5% (SE, 0.8%) for code 428 absent
(Table 2). In the multivariable ADHF validation models,
comorbid conditions such as acute myocardial infarction,
chronic kidney disease, and atrial fibrillation were statistically
significant predictors in each of the ICD-9-CM code 428 cat-
egories, while age group, race, and sex were not significant in
any of the 3 categories (Web Tables 9–11). Prediction of
ADHF improved for each of the ICD-9-CM 428 groups after
patient characteristics were taken into account (Web Fig-
ure 1). Predictive ability was better in the group with low
PPV (optimism-corrected AUCs were 0.73 (95% confidence
interval (CI): 0.72, 0.75) for 428 nonprimary and 0.81 (95%
CI: 0.79, 0.83) for 428 absent) than in the group with high
PPV (AUC = 0.63 (95% CI: 0.59, 0.67) for 428 primary).
During 1998–2011, the average annual number of hospi-
talizations for persons aged ≥55 years with 428 primary,
ARIC Study ADHF Surveillance
Hospitals within 4 US communities: 2005–2010
ADHF
(n = 21,757)
Not ADHF
(n = 30,308)
National Inpatient Sample
20% sample of US hospitals: 1998–2011
Hospitalized ADHF Validation Hospitalized ADHF Estimation
Eligible hospitalizations
(age ≥55 years with eligible ICD-9-CM codes)
n = 12,450; weighted total = 52,065 
Abstracted and adjudicated medical records Applied models to estimate the probability of
ADHF, by ICD-9-CM code 428 group 
Estimated ADHF hospitalization rates per 1,000
person-years in the US Census
Derived ADHF validation models using ICD-9-CM
code-based comorbidity, by ICD code 428 group
Eligible hospitalizations
(age ≥55 years with eligible ICD-9-CM codes)
n = 11.5 million; weighted total = 57.0 million
Estimated ADHF hospitalizations
Figure 1. Design of a study to estimate numbers and trends of acute decompensated heart failure (ADHF) hospitalization in the United States by
applying validation models derived from Atherosclerosis Risk in Communities (ARIC) Study ADHF surveillance (2005–2010) to the National Inpa-
tient Sample (1998–2011). Eligible International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes had the poten-
tial to identify ADHF hospitalizations. Three separate models were developed for groups with eligible ICD-9-CM codes: code 428 primary, code 428
nonprimary, and code 428 absent.
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428 nonprimary, and 428 absent discharge codes was 0.90
million, 2.68million, and 0.49million, respectively (Table 2).
The estimated number of ADHF hospitalizations per year
among the groups with 428 primary, nonprimary, and absent
codes was 0.80 million, 0.83 million, and 0.13 million, re-
spectively. Estimated numbers of ADHF hospitalizations
across groups summed to 1.76 million (95% CI: 1.71, 1.80)
per year. The estimated rates of ADHF hospitalization for
Table 1. Characteristics of Heart Failure-Eligiblea Hospitalizations (%) in ARIC Study Surveillance for Acute
Decompensated Heart Failure (2005–2010) and the National Inpatient Sample (1998–2010), by ICD-9-CM Code 428
Subgroupb
Position of ICD-9-CM Code 428 Among Discharge Diagnoses
ARIC Study ADHF Surveillance National Inpatient Sample
Primary
(n = 10,130)c
Nonprimary
(n = 36,410)
Absent
(n = 5,525)
Primary
(n = 12.6M)
Nonprimary
(n = 37.6M)
Absent
(n = 6.9M)
Age group, years
55–64 18.6 28.5 15.5 14.3 21.9 19.7
65–74 24.8 27.9 25.0 24.4 28.7 25.1
≥75 56.5 43.6 59.5 61.3 49.4 55.2
Male sex 43.9 46.3 44.9 44.1 47.0 47.8
Caucasian raced 73.3 70.7 60.2 61.3 60.2 69.3
Heart valve disorder 12.5 7.7 14.5 13.2 11.2 19.9
Rheumatic heart failure 0.1 7.4 1.6 0.1 12.6 0.0
Hypertension 43.9 50.7 39.8 40.0 35.6 45.2
Hypertensive heart failure 3.6 0.6 3.4 2.4 13.6 1.1
Diabetes 46.2 35.0 36.1 35.8 29.7 46.1
Coronary atherosclerosis 50.5 36.0 48.2 47.5 40.1 56.9
Acute myocardial infarction 8.2 4.3 8.5 10.5 6.5 3.7
Cardiomyopathy 10.6 43.2 14.8 9.3 40.6 15.2
Atrial fibrillation 36.2 26.5 33.7 33.8 28.3 39.0
Other arrhythmia (non-AF) 15.5 18.0 12.9 12.5 15.5 16.1
Conduction disorder 9.9 8.7 14.0 12.5 13.7 12.1
Chronic kidney disease 30.3 19.5 15.3 15.7 9.8 31.2
Acute kidney injury 21.5 14.0 12.5 13.9 8.8 14.0
Fluid and electrolyte disorder 11.0 10.3 6.2 6.8 6.5 6.9
Renal heart failure 3.4 0.4 2.0 1.9 5.3 0.8
Dyspnea and respiratory
abnormalities
2.3 41.9 3.8 1.0 23.8 2.6
COPD exacerbation 12.0 7.3 10.0 10.6 9.3 9.7
Pneumonia 19.8 11.9 15.8 18.7 11.5 13.3
Acute lung edema 0.1 0.2 4.4 0.0 0.1 2.7
Pulmonary heart diseasee 1.1 5.5 1.8 1.1 7.1 0.8
Anemia 26.6 18.8 15.7 15.8 13.1 24.8
Teaching hospital 38.8 36.7 39.6 40.3 39.0 32.3
Abbreviations: ADHF, acute decompensated heart failure; AF, atrial fibrillation; ARIC, Atherosclerosis Risk in
Communities; COPD, chronic obstructive pulmonary disease; ICD-9-CM, International Classification of Diseases,
Ninth Revision, Clinical Modification; M, million; NIS, National Inpatient Sample.
a Eligible samples of hospitalizations among persons aged ≥55 years were defined by hospital ICD-9-CM
discharge code as detailed in the Methods section of the text and Figure 1.
b ICD-9-CM 428 groups: the “primary” group had ICD-9-CM code 428.xx as the primary (first listed) discharge
diagnosis; the “nonprimary” group had ICD-9-CM code 428.xx in positions 2–26 of the discharge form; and the
“absent” (non-428) group had other eligible codes. The average sampling weight for both the ARIC and NIS
samples ranged from 2 to 6.
c Weighted number of hospitalizations.
d Estimated among persons with nonmissing values. Information on race was missing for 23% of eligible
hospitalizations in the NIS data.
e Acute/chronic heart disease related to the lungs, such as pulmonary hypertension, pulmonary embolism, or cor
pulmonale.
US Trends in ADHF Hospitalization 465
Am J Epidemiol. 2016;183(5):462–470
persons aged ≥55 years were 12.12, 12.26, and 1.96 per
1,000 person-years among those with 428 primary, non-
primary, and absent discharge codes, respectively, summing
to an estimated rate of ADHF of 26.3 per 1,000 person-years.
National temporal trends in heart failure codes and
estimated ADHF: 1998–2011
The estimates of total ADHF hospitalizations were similar
when different predictionmodels were used (unadjusted PPV,
demographics only, optimal, and full) and approximately 2
times higher than estimates of hospitalizations with 428 in
the primary position (Figure 2). The overall estimates ofADHF
hospitalizations obtained using a weighted sum of number of
hospitalizations in each ICD-9-CM group multiplied by re-
spective PPV were similar to those obtained with our model-
ing approach (Figure 2). Numbers of hospitalizations with
ICD-9-CM code 428 in the primary position increased
by 1.4% annually during 1998–2004 and then declined by
1.5% annually from 2005 through 2011 (Figure 3A, Web
Tables 12 and 13). In contrast, numbers of hospitalizations
with code 428 in a nonprimary position increased at a
much higher rate of 4.6% during 1998–2004, followed by a
statistically nonsignificant rise of 0.3% annually during
2005–2011. Starting in 2004, the percentage of estimated
ADHF hospitalizations from the ICD-9-CM 428 nonprimary
group was higher than the percentage from the 428
primary group (55% vs. 42% in 2011, with only 3% from
the 428-absent group; Figure 3B, Web Tables 13 and 14).
Compared with ADHF hospitalizations among 428-primary
hospitalizations, total estimated numbers of ADHF hospital-
izations increased at a higher rate during 1998–2004 (2.0%
vs. 1.5%, P < 0.001) and declined at a lower rate during
2005–2011 (−0.5% vs. −1.2%, P = 0.03). Allowing for
growth of the US population, rates of hospitalization for
ADHF decreased for all ICD-9-CM 428 groups throughout
the study period, except for the 428 nonprimary group during
1998–2004 (Figure 3C and 3D). The decline in the total es-
timated rate of ADHF hospitalization occurred at a slower
pace than the decline in ADHF among 428-primary
Table 2. Hospitalization Burden of Acute Decompensated Heart Failure and Temporal Trends in Acute Decompensated Heart Failure for Persons
Aged 55 Years or Older (Validated NIS Data Using ARIC Adjudication), United States, 1998–2011
Position of ICD-9-CM Code 428 Among Discharge Diagnoses
Total
Primary Nonprimary Absent
No., %, or
Rate
95% CI or
IQR
No., %, or
Rate
95% CI or
IQR
No., %,
or Rate
95% CI or
IQR
No., %, or
Rate
95% CI or
IQR
Eligiblea hospitalizations
ARIC Study ADHF surveillance,
2005–2010
Sample size (no. of hospitalizations) 2,083
(10,130)b
6,936
(36,410)
3,431
(5,525)
12,931
(54,851)
Validated ADHF positive predictive
value, %
90.2 88.7, 91.6 32.2 31.0, 33.4 16.5 15.1, 18.0
Probability of validated ADHF based
on the prediction models, %c
90.1 81.0–97.5 26.9 9.5–83.6 8.1 3.5–86.6
National Inpatient Sample, 1998–2011
Sample size (weighted no. of
hospitalizations), in millions
12.55 37.57 6.92 57.04
No. of eligible hospitalizations/year,
in millions
0.90 0.87, 0.92 2.68 2.51, 2.86 0.49 0.46, 0.53 4.07 3.94, 4.20
No. of ADHF hospitalizations/year,
in millionsd
0.80 0.79, 0.82 0.83 0.75, 0.90 0.13 0.09, 0.16 1.76 1.71, 1.80
Hospitalization rate per 1,000 person-years
Eligible hospitalizations 13.5 12.5, 14.5 40.0 38.7, 41.3 7.5 6.6, 8.4 61.0 59.2, 62.9
ADHF hospitalizationsd 12.1 11.3, 2.9 12.3 11.7, 12.8 2.0 1.4, 2.6 26.3 25.1, 27.6
Abbreviations: ADHF, acute decompensated heart failure; ARIC, Atherosclerosis Risk in Communities; CI, confidence interval; ICD-9-CM,
International Classification of Diseases, Ninth Revision, Clinical Modification; IQR, interquartile range; NIS, National Inpatient Sample.
a Eligible hospitalizations in both ARIC and the NIS were hospitalizations with index codes for identifying potential heart failure hospitalization
among persons aged ≥55 years.
b Numbers in parentheses, weighted number of hospitalizations.
c Values are presented as median (50th percentile) and IQR (25th–75th percentiles).
d ADHF validationmodels (Web Tables 9–11) included age, race, sex, and teaching hospital for all models and the following additional variables,
by model: code 428 in primary position—heart valve disease, chronic kidney disease, acute myocardial infarction, and atrial fibrillation; code 428 in
nonprimary position—acute myocardial infarction, other heart failure codes, pneumonia, code 428 in second position, acute kidney injury, atrial
fibrillation, chronic obstructive pulmonary disease, heart valve disorder, cardiomyopathy, fluid-electrolyte disorder, dyspnea-respiratory
abnormalities, hypertension, conduction disorder, and other cardiac arrhythmias; code 428 absent—other heart failure codes, acute myocardial
infarction, chronic kidney disease, fluid-electrolyte disorder, atrial fibrillation, and cardiomyopathy.
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hospitalizations during both periods (i.e., 1998–2004
(−0.1% vs. −0.7%, P < 0.001) and 2005–2011 (−3.2% vs.
−3.9%, P = 0.03)).
Sensitivity analyses
Sensitivity analyses were used to explore the robustness
of the findings by study community, study year, and model
assumptions. Thegoodness offitwas appropriate for eachmodel
according to ICD-9-CM code 428 group (Web Figure 2) and
was consistent by ARIC study center and study year (data not
shown).
When results were stratified by age group, the estimated
frequency and rate of ADHF hospitalizations were approxi-
mately twice those of code 428 primary hospitalizations in all
age groups. Comparing 428-primary and ADHF hospitaliza-
tions, similar trends were observed in the number of hospital-
izations, with the exception of persons aged 55–64 years after
2005 (−0.6% (95% CI: −1.3, 0) vs. 1.5% (95% CI: 0.6, 2.4))
and persons aged 65–74 years after 2005 (−2.2% (95% CI:
−3.1, −1.2) vs. −0.3% (95% CI: −1.3, 0.7)) (Web Figure 3).
DISCUSSION
Our study provides comprehensive estimates of the num-
ber and rate of ADHF hospitalizations during 1998–2011
in US adults aged 55 years or older, extending previous re-
ports that relied on ICD-9-CM code 428 in the primary
position on the hospital discharge form (4–7). Average an-
nual estimates of the number of ADHF hospitalizations
(1.76 million) were about 2 times higher than those based
on 428 codes in the primary position (0.90 million, including
0.80 million ADHF cases based on our prediction models).
Hospitalization trends differed by study period. Specifically,
total numbers of ADHF hospitalizations increased during
1998–2004, along with a rise in 428-primary hospitaliza-
tions. In contrast, numbers of ADHF hospitalizations were
stable during 2005–2011 despite a decrease in 428-primary
hospitalizations, due to an increase in ADHF cases without
code 428 in the primary position. Notably, a decrease in
428-primary hospitalizations has been reported for
Medicare-eligible patients, with a similar yearly rate of
change as observed by us (5), as well as nationally when es-
timated using NIS survey data (6, 7). Due to a parallel in-
crease in the US population, the rates of total ADHF were
stable during 1998–2004 and then declined slowly during
2005–2011, whereas the rates of 428-primary hospitaliza-
tions decreased throughout the study period.
Our results confirm the poor sensitivity of ICD-9-CM 428
codes in the primary position and indicate that only approx-
imately half of ADHF hospitalizations are tracked by this
code. We have shown that in 2011, more than half (55%)
of hospitalizations were identified by ICD-9-CM code 428
in nonprimary positions and a small proportion (3%) were
identified by non-428 eligible codes. The high proportion
of ADHF cases identified in the 428 nonprimary group
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Figure 2. Temporal trends in estimated numbers of US hospitalizations with acute decompensated heart failure (ADHF) and International Clas-
sification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) discharge code 428 in the primary position among persons aged≥55 years,
1998–2011. Data were obtained from the Atherosclerosis Risk in Communities Study and the National Inpatient Sample. Estimates of ADHF hos-
pitalization were obtained using various models (Web Table 14). PPV, positive predictive value.
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reflects a high proportion of hospitalizations with this code
and about one-third of them being adjudicated as ADHF. It is
likely that decompensation of heart failure may be precipi-
tated by another acute condition, like arrhythmia, myocardial
ischemia, or exacerbation of chronic obstructive pulmonary
disease, and discharge codes for these conditions may take
the primary position. The observed temporal decrease in
rates of hospitalization for ADHF for selected ICD-9-CM
groupings could be due to changing patterns in the placement
of ICD-9-CM code 428 in the secondary position versus the
primary position, possibly reflecting temporal changes in
comorbidity associated with ADHF. Whether any role was
played by improvements in themanagement of acute coronary
syndrome and care of chronic heart failure patients, as well as
hospital discharge planning and postdischarge follow-up, in-
troduced or emphasized by the heart failure management
guideline update published in 2005 (17) remains unclear.
Further work is needed to determine potential reasons for
the observed trends.
Heart failure affects approximately 5.7 million Americans,
and the associated costs of care are vast, driven primarily by
hospitalizations and frequent readmissions (25% are readmit-
ted within 1 month) (1, 18). The Hospital Readmissions Re-
duction Program of the Centers for Medicare and Medicaid
Services reduces payments to hospitals with excess readmis-
sions within 30 days of discharge (19). Both the rehospitaliza-
tion reduction program and performance measures target only
hospitalizations with ICD-9-CM code 428 in the primary po-
sition. Our findings suggest that reliance on primary 428 codes
may limit these efforts to fewer than half of ADHF hospitali-
zations. Strategies to appropriately include nonprimary 428
hospitalizations are needed. Algorithms which include a
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Figure 3. A) Temporal trends in numbers of US hospitalizations with International Classification of Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM) discharge code 428 primary, nonprimary, and absent among persons aged≥55 years, 1998–2011. B) Estimated (Est.) number of acute
decompensated heart failure (ADHF) hospitalizations contributed by each ICD-9-CM code group and their total. C) Rates of hospitalization per
1,000 persons based on panel A and the US Census. D) Estimated rates of ADHF hospitalization based on panel B. Data were obtained from
the Atherosclerosis Risk in Communities Study and the National Inpatient Sample. Corresponding annual percentage change in estimates is
shown in Web Table 12.
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broader range of codes should be more robust to changes in
billing and coding practices for continued surveillance. Of in-
terest, performance measures were poorer for hospitalizations
with 428 in a nonprimary position than for those with 428 in
the primary position, and associated 1-year mortality was
higher (20). Thus, appropriate algorithms focusing on ADHF
hospitalizations and not 428 primary hospitalizations may
allow targeted patient education programs to improve patient
care and outcomes and to reduce the number of heart failure
hospitalizations. Such algorithms may move the current focus
away from hospitalizations with 428 in the primary position
and toward ADHF hospitalizations in the Hospital Readmis-
sions Reduction Program, and could aid in attempts to remove
or reduce penalties for rehospitalization in more complex
cases. ADHF could develop during hospitalization, but in
the ARIC surveillance program, this occurred in only 7% of
the ADHF hospitalizations (21).
The impact of the transition to the International Classifica-
tion of Diseases, Tenth Revision, which offers higher granular-
ity for heart failure classification, will need to be evaluated, but
the position of the heart failure discharge codes (primary vs.
nonprimary) is likely to remain an important distinction. Fur-
ther, 40%–50% of patients with ADHF hospitalizations have
preserved ejection fraction, a subtype of heart failure associated
with a similar morbidity profile and costs of care as heart failure
with reduced ejection fraction but probably more favorable sur-
vival (2). The data presented for our study do not differentiate
among these subtypes, since most heart failure hospitalizations
are assigned the nonspecific ICD-9-CM code of 428.00.
Our results also suggest that the inpatient cost of care for
ADHF is considerably higher than that estimated for heart
failure hospitalizations identified merely from primary 428
codes. Further, although the rates of ADHF are declining,
the numbers of ADHF hospitalizations have not declined
and may impact future health-care costs.
Strengths
Our ADHF validation models were based on a large and
diverse sample of hospitalizations from more than 20 hospi-
tals in 4 regions of the United States, with rigorously stan-
dardized record abstraction and adjudication by a panel of
physician reviewers. The derivation estimates were stable
across time and geographic locales. These estimates were ap-
plied to the largest sample of US community hospitals available
and account for differences in comorbidity across hospitals
and settings, as well as adjust for any differences between
ARIC and NIS in the variables examined. Estimates based
on PPV alone were similar to model-based estimates, indicat-
ing robustness at the population level if much simpler models
are used to estimate overall ADHF burden.
Limitations
Our ADHF estimates only apply to community-based hos-
pitals, excluding federal hospitals suchas those in theVeterans
Affairs Health System, institutions such as nursing homes,
short observational stays, or emergency room discharges with-
out hospitalization. With the introduction of the International
Classification of Diseases, Tenth Revision, and penalties for
early readmissions, the observed validity of the heart failure
discharge codes and the performance of the ADHF prediction
models may change and may need recalibration in future
years. Despite the large size of the derivation sample, the
Community Surveillance Component of the ARIC Study
draws on only 4 regions of the country, extends only from
2005 to 2010, and is limited to persons aged 55 years or
older. Information on race was missing for a substantial pro-
portion of hospitalizations in the NIS data, but race was not
associated with the probability of ADHF in derivation data
and thus should not have influenced overall estimates. Reas-
suringly, the weighted proportions of eligible ICD-9-CM
codes, age group, and sex were similar in the derivation sam-
ple to those in the national sample of hospitals.
Conclusions
In the United States, there are 1.76 million hospitalizations
with ADHF each year on average, as compared with estimates
of 0.90 million per year based on ICD-9-CM code 428 in the
primary position. During 1998–2004, the total number of es-
timated ADHF hospitalizations increased at a higher rate than
hospitalizations with ICD-9-CM code 428 in the primary posi-
tion (2.0%/yearvs. 1.5%/year).During2005–2011, thenumber
of ADHF hospitalizations was stable, while previous reports,
as well as our study, demonstrated declines when ADHF hos-
pitalizations were defined by ICD-9-CM code 428 in the pri-
mary position. Given population growth, hospitalization rates
for ADHF were initially stable (1998–2004) and have slightly
declined recently (2005–2011). Our comprehensive estimates
of ADHF hospitalizations provide a better basis for estimating
inpatient heart failure costs and will be less sensitive to the
order of International Classification of Diseases codes to be
used to monitor and improve patient care.
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